ATE499117T1 - Mri-kontrastmediumzusammensetzung zur oralen verabreichung - Google Patents
Mri-kontrastmediumzusammensetzung zur oralen verabreichungInfo
- Publication number
- ATE499117T1 ATE499117T1 AT09153742T AT09153742T ATE499117T1 AT E499117 T1 ATE499117 T1 AT E499117T1 AT 09153742 T AT09153742 T AT 09153742T AT 09153742 T AT09153742 T AT 09153742T AT E499117 T1 ATE499117 T1 AT E499117T1
- Authority
- AT
- Austria
- Prior art keywords
- mri contrast
- oral administration
- contrast media
- media composition
- promoter
- Prior art date
Links
- 239000002872 contrast media Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 229940039231 contrast media Drugs 0.000 title 1
- 210000004185 liver Anatomy 0.000 abstract 2
- 239000011572 manganese Substances 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000003384 imaging method Methods 0.000 abstract 1
- -1 manganese (II) compound Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0303429A SE527491C2 (sv) | 2003-12-19 | 2003-12-19 | Kontraktsmedelskomposition för magnetisk resonanstomografi för oral administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE499117T1 true ATE499117T1 (de) | 2011-03-15 |
Family
ID=30768766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09153742T ATE499117T1 (de) | 2003-12-19 | 2004-11-10 | Mri-kontrastmediumzusammensetzung zur oralen verabreichung |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070065520A1 (de) |
| EP (2) | EP2060273B1 (de) |
| JP (1) | JP4731493B2 (de) |
| KR (1) | KR101131362B1 (de) |
| AT (1) | ATE499117T1 (de) |
| AU (1) | AU2004298396B2 (de) |
| CA (1) | CA2549890C (de) |
| DE (1) | DE602004031569D1 (de) |
| DK (1) | DK2060273T3 (de) |
| ES (1) | ES2363917T3 (de) |
| NO (1) | NO20063106L (de) |
| RU (1) | RU2361618C2 (de) |
| SE (1) | SE527491C2 (de) |
| TW (1) | TWI334787B (de) |
| WO (1) | WO2005058375A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011003818A2 (en) | 2009-07-06 | 2011-01-13 | Cmc Contrast Ab | Diagnostic method |
| CN105658786B (zh) | 2013-08-28 | 2020-07-03 | 普罗米迪拉生物科学公司 | 用于生产成人肝脏祖细胞的方法 |
| CN106795489B (zh) | 2014-08-28 | 2021-07-06 | 信铭普罗米迪拉亚洲有限公司 | 用于生产成人肝脏祖细胞的方法 |
| RU2577298C1 (ru) * | 2014-10-01 | 2016-03-10 | Общество с ограниченной ответственностью "МедКонтрастСинтез" (ООО "МедКонтрастСинтез") | Гепатотропное магнитно-резонансное средство |
| KR101864992B1 (ko) * | 2017-03-09 | 2018-07-04 | 국립암센터 | Mri 노이즈 제거용 조성물 및 이를 이용한 패드 |
| KR102381029B1 (ko) * | 2019-04-05 | 2022-03-31 | 연세대학교 산학협력단 | 대사체를 유효성분으로 포함하는 신규한 조영제 조성물 |
| JP2022535874A (ja) | 2019-06-07 | 2022-08-10 | アスセリア ファーマ エービー | Ｍｒｉ用圧縮固形組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4863898A (en) * | 1986-02-06 | 1989-09-05 | Albion International, Inc. | Amino acid chelated compositions for delivery to specific biological tissue sites |
| DK531488A (da) | 1987-09-25 | 1989-03-26 | Salutar Inc | Nmr-billeddannelse med mn(ii)-koordinationsforbindelser |
| WO1996005867A2 (en) | 1994-08-18 | 1996-02-29 | Nycomed Imaging A/S | Compositions |
| DK81095A (da) * | 1995-07-11 | 1997-01-12 | Henrik S Thomsen | Peroralt MR-kontraststof til lever og øvre tarmkanal |
| GB9619758D0 (en) * | 1996-09-23 | 1996-11-06 | Nycomed Imaging As | Method |
| WO1998011922A2 (en) * | 1996-02-16 | 1998-03-26 | Nycomed Imaging As | Method |
-
2003
- 2003-12-19 SE SE0303429A patent/SE527491C2/sv not_active IP Right Cessation
-
2004
- 2004-11-10 ES ES09153742T patent/ES2363917T3/es active Active
- 2004-11-10 RU RU2006126072/15A patent/RU2361618C2/ru not_active IP Right Cessation
- 2004-11-10 KR KR1020067014025A patent/KR101131362B1/ko not_active IP Right Cessation
- 2004-11-10 JP JP2006545274A patent/JP4731493B2/ja not_active Expired - Fee Related
- 2004-11-10 US US10/583,317 patent/US20070065520A1/en not_active Abandoned
- 2004-11-10 EP EP09153742A patent/EP2060273B1/de not_active Not-in-force
- 2004-11-10 AT AT09153742T patent/ATE499117T1/de not_active IP Right Cessation
- 2004-11-10 AU AU2004298396A patent/AU2004298396B2/en not_active Ceased
- 2004-11-10 CA CA2549890A patent/CA2549890C/en not_active Expired - Fee Related
- 2004-11-10 WO PCT/SE2004/001644 patent/WO2005058375A1/en active Application Filing
- 2004-11-10 DK DK09153742.3T patent/DK2060273T3/da active
- 2004-11-10 DE DE602004031569T patent/DE602004031569D1/de active Active
- 2004-11-10 EP EP04800307A patent/EP1694367A1/de not_active Withdrawn
- 2004-11-12 TW TW093134585A patent/TWI334787B/zh not_active IP Right Cessation
-
2006
- 2006-07-04 NO NO20063106A patent/NO20063106L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2549890C (en) | 2012-09-18 |
| ES2363917T3 (es) | 2011-08-19 |
| EP2060273A3 (de) | 2009-09-30 |
| TWI334787B (en) | 2010-12-21 |
| SE0303429D0 (sv) | 2003-12-19 |
| SE0303429L (sv) | 2005-06-20 |
| SE527491C2 (sv) | 2006-03-21 |
| EP1694367A1 (de) | 2006-08-30 |
| DK2060273T3 (da) | 2011-05-23 |
| NO20063106L (no) | 2006-09-18 |
| TW200520777A (en) | 2005-07-01 |
| AU2004298396A1 (en) | 2005-06-30 |
| KR101131362B1 (ko) | 2012-04-04 |
| US20070065520A1 (en) | 2007-03-22 |
| EP2060273A2 (de) | 2009-05-20 |
| WO2005058375A1 (en) | 2005-06-30 |
| DE602004031569D1 (de) | 2011-04-07 |
| JP2007514740A (ja) | 2007-06-07 |
| EP2060273B1 (de) | 2011-02-23 |
| AU2004298396B2 (en) | 2010-06-17 |
| RU2006126072A (ru) | 2008-01-27 |
| JP4731493B2 (ja) | 2011-07-27 |
| KR20070027501A (ko) | 2007-03-09 |
| CA2549890A1 (en) | 2005-06-30 |
| RU2361618C2 (ru) | 2009-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063106L (no) | MRI-kontrastmediumsammensetning for oral administrasjon | |
| ES2527918T3 (es) | Descodificador multi-canal binaural en el contexto de reglas de mezcla ascendente que no conservan la energía | |
| CR20110483A (es) | Preparacion de pregabalina y compuestos relacionados (divisional de expediente 8765) | |
| CY1109722T1 (el) | Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole | |
| EP1490483A4 (de) | In-vivo-einbau von nicht in der natur vorkommenden aminosäuren | |
| WO2002085903A3 (en) | Amyloid plaque aggregation inhibitors and diagnostic imaging agents | |
| ATE527552T1 (de) | Mr-darstellungsverfahren zur diskriminierung zwischen gesundem und tumorgewebe | |
| EP1881008A4 (de) | Verfahren zur in-vitro-diagnose von alzheimer-krankheit mit einem monoklonalen antikörper | |
| BRPI0608376A8 (pt) | composição de ligação, método de uso de uma composição de ligação, e, kit de detecção | |
| DK2000545T3 (da) | Sammensætninger og fremgangsmåder til diagnose og behandling af lunge-tumor | |
| DK1458760T3 (da) | Indfangede bindingsproteiner som biosensorer | |
| CY1117449T1 (el) | Φαινυλιουχα ν-ακυλο παραγωγα αμινων και αμινοξεων, μεθοδοι για την παραγωγη αυτων, μια φαρμακευτικη συνθεση και η χρηση αυτων | |
| WO2004091497A3 (en) | Methods and compositions for increasing the anaerobic working capacity in tissues | |
| EP2368995A3 (de) | Verfahren zur Isolierung von löslichen Polypeptiden | |
| DK2157192T3 (da) | Sammensætninger til diagnose og terapi af sygdomme forbundet med afvigende ekspression af futriner (R-spondiner) | |
| BRPI0518328A2 (pt) | agente de contraste, composiÇço farmacÊutica, uso de um agente de contraste, mÉtodo para gerar imagens realÇadas de um corpo animal ou humano, e, kit para a preparaÇço de um composiÇço radiofarmacÊutica | |
| ATE383854T1 (de) | Kombination ausgewählter opioide mit muscarin- antagonisten zur therapie der harninkontinenz | |
| WO2007042791A3 (en) | Automated radiolabelling method | |
| CY1113871T1 (el) | Διαδικασια παρασκευης γκαμπαπεντινης | |
| EP2168442A3 (de) | Geranylaminderivate der Oxalsäure | |
| MXPA03004499A (es) | Kit de repinotan. | |
| CY1107028T1 (el) | Παραγωγα ινδανυλ-πιπεραζινων μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
| NO20034504D0 (no) | Erytropoietin forbedrer in vivo kjemoterapiindusert toksisitet | |
| ATE529445T1 (de) | Biokinetik zur schnellen beseitigung von polypeptiden | |
| ATE366122T1 (de) | Mikrowellenverfahren zur herstellung von radiomarkierten gallium komplexe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |